中国广州儿童疫苗接种后百日咳、白喉、破伤风、麻疹、腮腺炎和风疹抗体血清阳性率:一项横断面研究
该横断面研究对广州620名按计划免疫接种的儿童,采用酶联免疫吸附试验检测百日咳、白喉、破伤风、麻疹、腮腺炎和风疹六种疾病的IgG抗体浓度及血清阳性率。结果显示白喉、破伤风、麻疹和风疹的免疫状态相对满意,而百日咳和腮腺炎相对较低。作者建议考虑在适当时机对百日咳和腮腺炎进行加强接种。
要点
- 麻疹、破伤风、风疹的血清阳性率和IgG浓度均为女性高于男性。
- 白喉、破伤风、麻疹和风疹的血清阳性率在初种和首次加强接种后达到峰值。
- 百日咳和腮腺炎免疫状态相对较低,作者建议考虑适时加强接种。
核心结论
- 白喉、破伤风、麻疹和风疹的疫苗接种后免疫状态相对满意,而百日咳和腮腺炎相对较低。
- 作者建议应考虑在适当时机对百日咳和腮腺炎进行加强接种。
研究设计与样本
- 横断面研究,聚焦按计划免疫接种儿童的疫苗接种后免疫状态,共纳入620名儿童,男女比为2.04(416/204)。
- 采用商业化酶联免疫吸附试验试剂盒检测六种疾病的人IgG抗体。
主要发现
- 麻疹血清阳性率女性81.97% vs 男性90.20%,IgG浓度女性686.55 IU/mL vs 男性884.26 IU/mL(P < 0.05)。
- 破伤风IgG浓度女性0.94 IU/mL vs 男性1.21 IU/mL,风疹IgG浓度女性34.33 IU/mL vs 男性47.37 IU/mL,均为女性更高。
- 抗百日咳抗体、抗白喉抗体和抗腮腺炎抗体的血清阳性率和IgG浓度未见性别差异。
- 抗百日咳抗体在初种和加强接种后血清阳性率和IgG浓度略有升高(从0.00%[1月龄]、5.45%[6月龄]至17.14%[1.5岁];从8.57%[5岁]至15.79%[6岁]),6岁后未给予加强接种但保持相对稳定。
- 腮腺炎在1.5岁含腮腺炎成分疫苗初种后血清阳性率和IgG浓度从7.14%升至57.14%、从52.13 IU/mL升至214.18 IU/mL,此后观察到低血清阳性率水平(从42.86%至80.00%)。
关键数值与推荐
- 男女性别比为2.04(416/204),共620名受试者。
临床怎么用
- 作者建议应考虑在适当时机对百日咳和腮腺炎进行加强接种。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This study investigated the concentrations and seroprevalence of immunoglobulin G (IgG) antibodies against pertussis, diphtheria, tetanus, measles, mumps and rubella among children in Guangzhou, China. We conducted a cross-sectional study focusing on the post-vaccination immune statuses of children on scheduled immunisation. Human IgG antibody against six diseases were measured using commercial enzyme-linked immunosorbent assay kits. Of 620 subjects, the male-to-female ratio was 2.04 (416/204). Seroprevalence (81.97% vs 90.20%) and IgG concentrations (686.55 IU/mL vs 884.26 IU/mL, P < 0.05) for measles, tetanus (0.94 IU/mL vs 1.21 IU/mL) and rubella (34.33 IU/mL vs 47.37 IU/mL) were all higher in females. No differences based on sex were observed in the seroprevalence and IgG concentrations for anti-pertussis antibodies, anti-diphtheria antibodies and anti-mumps. Slight increase in seroprevalence and IgG concentration occurred with anti-pertussis antibodies after primary and booster vaccinations (from 0.00% [1 m], 5.45% [6 m], to 17.14% [1.5 yr]; and from 8.57% [5 yr] to 15.79% [6 yr]). Although no booster vaccination was given after age 6 yr, the seroprevalence and IgG concentration for anti-pertussis antibodies remained relatively stable. For diphtheria, tetanus, measles and rubella, seroprevalence reached their peaks after the primary and first booster vaccination. A plateau occurred after age 1.5 yr with a declining trend in subjects >8-10 yr. The IgG concentrations of these 4 pathogens showed a dramatic increase after primary vaccination, with steadily declining trends thereafter. For mumps, subjects showed increased seroprevalence and IgG concentration after the primary mumps-containing vaccination in 1.5-yr-olds (from 7.14% to 57.14%; 52.13 IU/mL to 214.18 IU/mL); however, following that low seroprevalence levels (from 42.86% to 80.00%) were observed. The post-vaccination immune statuses against diphtheria, tetanus, measles and rubella were relatively satisfactory, compared to those against pertussis and mumps. Booster vaccination against pertussis and mumps at appropriate time should be considered.
引用
- Li YT, Luo XQ, Zhong XB, et al. Seroprevalences of antibodies against pertussis, diphtheria, tetanus, measles, mumps and rubella: A cross-sectional study in children following vaccination procedure in Guangzhou, China. Vaccine. 2020. PMID: 32321685. doi:10.1016/j.vaccine.2020.03.056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。